Literature DB >> 11174022

Serological and vaccination profile of hemodialysis patients during an outbreak of hepatitis B virus infection.

L L Lewis-Ximenez1, J M Oliveira, L A Mercadante, L De Castro, W Santa Catharina, S Stuver, C F Yoshida.   

Abstract

During an outbreak of hepatitis B virus (HBV) infection in a hemodialysis unit, patients were assessed for serological viral markers and vaccination status. HBV infection was identified in 26 patients. Twenty of these were positive for hepatitis B surface antigen (HBsAg), and 6 were negative for HBsAg but positive for IgM antibody to hepatitis B core (anti-HBc) and HBV DNA. The primary source of infection was not clearly identified, although 2 patients were suspected to be the index cases. A multiple logistic regression analysis revealed low anti-HBs titers and vaccination status to be independently associated with the risk of acquiring HBV infection. Both the high prevalence of HBV infection (31%) detected in this unit and the low vaccine response (53%) observed reinforce the importance of universal and preventive measures in controlling HBV infection. The detection of HBV DNA in HBsAg-negative/IgM anti-HBc-positive patients emphasizes the value of anti-HBc testing in the routine screening of HBV in hemodialysis units. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11174022     DOI: 10.1159/000045880

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  2 in total

1.  Improving hepatitis B vaccine efficacy in end-stage renal diseases patients and role of adjuvants.

Authors:  Mohammad Hossein Somi; Babak Hajipour
Journal:  ISRN Gastroenterol       Date:  2012-09-18

2.  Risk factors for hepatitis B virus infection in Rio de Janeiro, Brazil.

Authors:  Lia L Lewis-Ximenez; Kycia M R do O; Cleber F Ginuino; Jucimara C Silva; Hermann G Schatzmayr; Sherri Stuver; Clara F T Yoshida
Journal:  BMC Public Health       Date:  2002-11-22       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.